To maintain a safe and constructive environment, comments that include profanity or violent, threatening language will be hidden
At this time, it is uncertain how participating beneficiaries will be able to maintain Medicare coverage of their GLP-1 medication for obesity after the Medicare GLP-1 Bridge ends at the end of 2027, pending further action from CMS to implement the BALANCE Model in Medicare Part D in 2028, as described below
Under this program CMS negotiates a Maximum Fair Price (MFP) for certain high expenditure, single source drugs
Whether youre struggling with weight, body image, or co-occurring mental health conditions, safe, supervised care is the best path forward
Remember, things like stress and poor sleep can affect your weight more than medication